<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4104550/" ref="ordinalpos=4618&amp;ncbi_uid=6469048&amp;link_uid=PMC4104550" image-link="/pmc/articles/PMC4104550/figure/F1/" class="imagepopup">Figure 1.  From: A Systemic Review of Resistance Mechanisms and Ongoing Clinical Trials in ALK-Rearranged Non-Small Cell Lung Cancer. </a></div><br /><div class="p4l_captionBody"><b>The ALK signaling pathway with its cross-talk with other pathways involved in the resistance to ALK-inhibitors</b>. Adapted from Tabbo et al. (47).</div></div>